Brightsurf Science News & Current Events

February 06, 2007
New pan-European guidelines on the treatment of diabetes, cardiovascular and VHD published
The first, pan-European guidelines to be published on the treatment of valvular heart disease, diabetes and cardiovascular diseases have made a series of new recommendations which experts hope will contribute to improving the outcome of patients with these diseases.

Statin therapy associated with regression of coronary atherosclerosis with key lipid level changes
An analysis of data from four clinical trials suggests that statin therapy is associated with regression of coronary atherosclerosis when low-density lipoprotein cholesterol (LDL-C or

Researchers identify 5 genetic variations associated with risk of venous thrombosis in women
Researchers have identified new genetic variations that may be associated with the risk of developing nonfatal venous thrombosis in postmenopausal women, according to a study in the Feb.

Action video games sharpen vision 20 percent
Video games that contain high levels of action, such as Unreal Tournament, can actually improve your vision.

Better assessment of transfusions could save blood
Nearly 95 percent of patients admitted to hospital intensive care units are affected by anemia.

Powerful ally in life sciences: UH research head to give keynote
BioHouston, a 501(c)(3) founded by regional academic and research institutions, is featuring UH's new head of research, Donald Birx, as a keynote speaker Wednesday, Feb.

Mind-set matters -- Why thinking you got a work out may actually make you healthier
A new study shows that many of the beneficial results of exercise may be due to the placebo effect.

Return on investment for pediatric exclusivity program varies widely for pharmaceutical companies
The economic return for a program designed to encourage drug manufacturers to conduct more pediatric clinical trials by granting extensions of patent protection or marketing exclusivity generates lucrative returns for blockbuster products and produces more modest returns on investment for many others, according to a study in the Feb.

Power-boosting signal in muscle declines with age
As people age, they may have to exercise even harder to get the benefits afforded to younger folk.

Brown cancer biologists identify major player in cell growth
The transcription factor GABP -- a member of a family of crucial gene-regulating proteins -- is required to jump-start the process of cell division, according to research from The Warren Alpert Medical School of Brown University and Rhode Island Hospital.

Immigration slows rate of racial and ethnic intermarriages
Immigration has played a key role in unprecedented declines in interracial and inter-ethnic marriage in the United States during the 1990s, according to a new study.

Vitamins: Science doesn't always match policy
A gap exists between scientific knowledge of vitamins and how they are popularly used.

New player in commitment to life as a fat cell
Researchers have discovered a pivotal new player in early events that commit fat cell precursors to becoming full-blown fat, according to a report in the February issue of the journal Cell Metabolism, published by Cell Press.

Cambodian vulture nests offer hope for species
Working in the remote forests of Cambodia, conservationists from the Wildlife Conservation Society have just discovered Southeast Asia's only known breeding colony of slender-billed vultures, one of the world's most threatened bird species.

Selectivity is ultimate aphrodisiac
Speed daters who romantically desired most of their potential partners were rejected overwhelmingly, according to a new Northwestern University study.

2 new studies back vitamin D for cancer prevention
Two new vitamin D studies using a sophisticated form of analysis called meta-analysis, in which data from multiple reports is combined, have revealed new prescriptions for possibly preventing up to half of the cases of breast cancer and two-thirds of the cases of colorectal cancer in the United States.

Preclinical results of Geovax's AIDS vaccines demonstrate potential to protect against disease
GeoVax Labs Inc., an Atlanta-based biotechnology company, today reported successful results from a preclinical trial using GeoVax's vaccines for the therapeutic treatment and prevention of AIDS in non-human primates.

Taking heart failure to the MAT1
A gene called ménage-à-trois 1, or MAT1, plays a crucial role in the function of a master switch for production of energy in the heart cell -- a finding that has important implications for understanding and maybe even treating heart failure.

Man-made proteins could be more useful than real ones
Researchers have constructed a protein out of amino acids not found in natural proteins, forming a complex, stable structure closely resembling a natural protein.

Penn awarded $2M grant from Keck Foundation for fundamental research on Parkinson's disease
The University of Pennsylvania has received a $2 million grant from the W.M.

Volcanoes and nanotechnology
Since their discovery, carbon nanotubes and carbon nanofibers have been used in a wide variety of applications.

Improved imaging for identifying breast cancer in overweight women
Increasing the ability to identify sentinel nodes -- the very first lymph nodes that trap cancer cells draining away from a breast lesion site -- has a major impact in the treatment and outcome of breast cancer patients, possibly eliminating the need for unnecessary and painful surgery.

Male sweat boosts women's hormone levels
Male sweat, and one particular chemical in male sweat, is known to influence women's moods, and even increase their sexual arousal.

Woven scaffolds could improve cartilage repair
Using a unique weaving machine of their design, Duke University Medical Center researchers have created a three-dimensional fabric

Do cigarette warning labels work -- results from 4 countries
As the second leading cause of death in the world, cigarette smoking is a preventable behavior.

WEHI enters research collaboration with Genentech, Inc.
The Walter and Eliza Hall Institute of Medical Research (WEHI) announced today that it has entered into an exclusive global collaboration agreement with the California-based biotech company Genentech, Inc. to discover, develop, manufacture and commercialize a new class of broad spectrum cancer therapeutics.

Majority of English homeowners keep all financial eggs in one basket
Nearly two-thirds (65 percent) of homeowners in a study of English mortgage holders store almost all their savings in one single asset -- their own home -- new academic research from Durham University suggests.

News tips from the Journal of Neuroscience
The following articles are featured in the upcoming issue of the Journal of Neuroscience:

Other highlights in the February 7 JNCI
Also in the February 7 JNCI, an article on second cancers among hairy cell leukemia survivors, a test to identify types of colorectal cancer, a report on problems with tumor markers, and a examination of a growth factor that may interfere with blood cell production.

Lombardi expert helps set new guidelines for assessing lymphoma treatment
An international team of cancer specialists and imaging experts, including Bruce Cheson, professor of medicine, head of hematology, and director of hematology research at Georgetown's Lombardi Comprehensive Cancer Center, has developed standardized guidelines for assessing how lymphomas respond to treatment.

Physicists achieve all-optical buffering of images
Researchers at the University of Rochester have demonstrated that optical pulses in an imaging system can be buffered in a slow-light medium, while preserving the information of the image.

Green payments are the future of agricultural support
The federal Conservation Security Program rewards farmers for land stewardship, yet many New England farmers were not eligible to participate.

Major society publisher announces support for public access to scientific literature
The American Society for Cell Biology, a nonprofit scientific society of over 11,000 members and publisher of the high-impact monthly journal, Molecular Biology of the Cell, has announced its

FDA's modern risk-based approach opens dialogue with industry
AAPS and ISPE are pleased to present the FDA's Pharmaceutical Quality Initiatives: Implementation of a Modern Risk-Based Approach, an interactive workshop that will serve as an open forum for industry, other stakeholders and the public to take part in the dialogue about the future of pharmaceutical manufacturing.

No reliable risk factors found for CA-MRSA
Loren Miller, M.D., M.P.H. has found no reliable epidemiological or clinical risk factors that could distinguish patients with CA-MRSA infection from patients with CA-MSSA infection.

Common anesthetic may induce cell death, generation of Alzheimer's-associated protein
A new study has found how one of the most commonly used anesthetics may produce Alzheimer's-like changes in the brain.

First Lancet medical forum on cancer management to be held in Asia
The Lancet's first forum on cancer management will be held in Singapore in April (Suntec International Convention and Exhibition Centre, Singapore, April 21-22, 2007).

Are we killing the world's oceans?
Leading international ocean and climate researchers and government decision-makers will gather at the University of Victoria in British Columbia Feb.

Methane bubbling through seafloor creates undersea hills
According to a recent paper published by MBARI geologists and their colleagues, methane gas bubbling through seafloor sediments has created hundreds of low hills on the floor of the Arctic Ocean.

Prevalence of overactive bladder is overestimated
An article published in PLoS ONE on Feb. 7 demonstrates that overactive bladder occurs in one Finn out of 12 (8 percent), whereas earlier studies outside Finland estimate a frequency of one in six.

Researchers discover master metabolism regulator with profound effect on fat metabolism
Researchers have discovered an enzyme that has an unexpectedly profound impact on fat metabolism.

Feb. 16 event explores pills, politics and the public trust
The pharmaceutical industry is one of America's favorite punching bags.

Human trial results show excellent safety data, from Geovax's DNA/MVA AIDS vaccines
GeoVax Labs Inc. an Atlanta-based biotechnology company, today reported successful early results from two ongoing AIDS prevention Phase I human vaccine trials.

Human's ecological footprint in 2015 and Amazonia revealed
In the February issue of Frontiers in Ecology and the Environment, a recent study shows human population size and affluence are the main drivers of human-caused environmental stressors, while urbanization, economic structure and age of population have little effect.

Drug used in coronary artery bypass graft surgery may increase risk of death
Aprotinin, a drug used for limiting blood loss in patients undergoing cardiac surgery, is associated with an increased risk of death during five years following the surgery, according to a new study in the Feb.

Universe contains more calcium than expected
The universe contains one-and-a-half times more calcium than previously assumed.

Soft-cell approach cuts animal tests
A new way to test the safety of the air we breathe is proving faster, cheaper and more humane than exposing laboratory animals to airborne chemical hazards, say UNSW scientists.

Interfering with vagal nerve activity in mice prevents diabetes and hypertension
Interrupting nerve signals to the liver can prevent diabetes and hypertension in mice, according to scientists at Washington University School of Medicine in St.

Asia-European collaboration addresses water management in Indonesia
University of Leicester environmentalists are leading an international team in a research project that can help Indonesian researchers to reverse strategies that have resulted in inefficient water management which threatens local communities.

Growth factors given with chemotherapy associated with increased risk of blood diseases
Women with breast cancer who receive compounds that stimulate white blood cell production to help their bodies better tolerate chemotherapy are at an increased risk of developing a type of leukemia or a condition called myelodysplastic syndrome, according to a new study in the February 7, Journal of the National Cancer Institute.

Navigable nanotransport
To accurately transport pharmaceutical agents to their specific target organs or cell types, you need a good carrier: Nanoscopic capsules with surface elements that can

Study analyzes heart attack mortality risk associated with Hodgkin disease treatments
Doctors have long known that patients treated for Hodgkin disease are at an increased risk for heart attacks.

Aging population is causing major increase in the cancer burden warn experts
Between 2004 and 2006, the number of new cases of cancer diagnosed each year in Europe has increased by 300,000 according to new estimates in a report by Peter Boyle in Annals of Oncology. is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to